DARC (Duffy) and BCAM (Lutheran) reduced expression in thyroid cancer

Blood Cells, Molecules, and Diseases

Volumn 50, Issue 3, 2013, Pages 161-165

  Latini, Flavia Roche Moreira ^a   Bastos, André Uchimura ^b   Arnoni, Carine Prisco ^a   Muniz, Janaína Guilhem ^a   Person, Rosangela Medeiros ^a   Baleotti, Wilson ^c   Barreto, José Augusto ^a   Castilho, Lilian ^d   Cerutti, Janete Maria ^b  

^a Laboratório de Espectrometria de Massas Associação Beneficente de Coleta de Sangue   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Faculdade de Medicina Estadual de Marilia FAMEMA   (Brazil)

^d UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

BCAM; Cancer; DARC; Duffy; Lutheran; Thyroid

Indexed keywords

BASAL CELL ADHESION MOLECULE; CELL ADHESION MOLECULE; DUFFY ANTIGEN RECEPTOR FOR CHEMOKINE; DUFFY BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CLASSICAL VARIANT OF PAPILLARY THYROID CARCINOMA; CONTROLLED STUDY; FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; THYROID CANCER; THYROID FOLLICULAR ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TUMOR MICROENVIRONMENT; TUMOR VOLUME;

CARCINOMA; CELL ADHESION MOLECULES; DUFFY BLOOD-GROUP SYSTEM; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUTHERAN BLOOD-GROUP SYSTEM; NEOPLASM METASTASIS; RECEPTORS, CELL SURFACE; THYROID NEOPLASMS; TUMOR BURDEN;

EID: 84873250192     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2012.10.009     Document Type: Article

References (27)

1. Daniels G. Functions of red cell surface proteins. Vox Sang. 2007, 93:331-340.
2. Cartron J.P., Colin Y. Structural and functional diversity of blood group antigens. Transfus. Clin. Biol. 2001, 8:163-199.
3. Rojewski M.T., Schrezenmeier H., Flegel W.A. Tissue distribution of blood group membrane proteins beyond red cells: evidence from cDNA libraries. Transfus. Apher. Sci. 2006, 35:71-82.
4. Garratty G. Blood group antigens as tumor markers, parasitic/bacterial/viral receptors, and their association with immunologically important proteins. Immunol. Invest. 1995, 24:213-232.
5. Mantovani A., Bonecchi R., Locati M. Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat. Rev. Immunol. 2006, 6:907-918.
6. Zeng X.H., Ou Z.L., Yu K.D., et al. Coexpression of atypical chemokine binders (ACBs) in breast cancer predicts better outcomes. Breast Cancer Res. Treat. 2011, 125:715-727.
7. Wang J., Ou Z.L., Hou Y.F., et al. Duffy antigen receptor for chemokines attenuates breast cancer growth and metastasis: an experiment with nude mice. Zhonghua Yi Xue Za Zhi 2005, 85:2033-2037.
8. Wang J., Ou Z.L., Hou Y.F., et al. Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential. Oncogene 2006, 25:7201-7211.
9. Addison C.L., Belperio J.A., Burdick M.D., Strieter R.M. Overexpression of the Duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis. BMC Cancer 2004, 4:28.
10. Sun G., Wang Y., Zhu Y., Huang C., Ji Q. Duffy antigen receptor for chemokines in laryngeal squamous cell carcinoma as a negative regulator. Acta Otolaryngol. 2011, 131:197-203.
11. Collec E., Lecomte M.C., El Nemer W., Colin Y., Le Van Kim C. Novel role for the Lu/BCAM-spectrin interaction in actin cytoskeleton reorganization. Biochem. J. 2011, 436:699-708.
12. Kroviarski Y., El Nemer W., Gane P., et al. Direct interaction between the Lu/B-CAM adhesion glycoproteins and erythroid spectrin. Br. J. Haematol. 2004, 126:255-264.
13. Bernemann T.M., Podda M., Wolter M., Boehncke W.H. Expression of the basal cell adhesion molecule (B-CAM) in normal and diseased human skin. J. Cutan. Pathol. 2000, 27:108-111.
14. Drewniok C., Wienrich B.G., Schon M., et al. Molecular interactions of B-CAM (basal-cell adhesion molecule) and laminin in epithelial skin cancer. Arch. Dermatol. Res. 2004, 296:59-66.
15. Schon M., Klein C.E., Hogenkamp V., et al. Basal-cell adhesion molecule (B-CAM) is induced in epithelial skin tumors and inflammatory epidermis, and is expressed at cell-cell and cell-substrate contact sites. J. Invest. Dermatol. 2000, 115:1047-1053.
16. Yu K.H., Barry C.G., Austin D., et al. Stable isotope dilution multidimensional liquid chromatography-tandem mass spectrometry for pancreatic cancer serum biomarker discovery. J. Proteome Res. 2009, 8:1565-1576.
17. Nikiforov Y.E., Nikiforova M.N. Molecular genetics and diagnosis of thyroid cancer. Nat. Rev. Endocrinol. 2011, 7:569-580.
18. Latini F.R., Hemerly J.P., Oler G., Riggins G.J., Cerutti J.M. Re-expression of ABI3-binding protein suppresses thyroid tumor growth by promoting senescence and inhibiting invasion. Endocr. Relat. Cancer 2008, 15:787-799.
19. Buckhaults P., Rago C., St Croix B., et al. Secreted and cell surface genes expressed in benign and malignant colorectal tumors. Cancer Res. 2001, 61:6996-7001.
20. Cerutti J.M., Delcelo R., Amadei M.J., et al. A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression. J. Clin. Invest. 2004, 113:1234-1242.
21. Schlumberger M.J. Papillary and follicular thyroid carcinoma. N. Engl. J. Med. 1998, 338:297-306.
22. Muzza M., Degl'Innocenti D., Colombo C., et al. The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies. Clin. Endocrinol. (Oxf) 2010, 72:702-708.
23. Kondo T., Ezzat S., Asa S.L. Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat. Rev. Cancer 2006, 6:292-306.
24. Dawson T.C., Lentsch A.B., Wang Z., et al. Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC). Blood 2000, 96:1681-1684.
25. Planaguma J., Liljestrom M., Alameda F., et al. Matrix metalloproteinase-2 and matrix metalloproteinase-9 codistribute with transcription factors RUNX1/AML1 and ETV5/ERM at the invasive front of endometrial and ovarian carcinoma. Hum. Pathol. 2011, 42:57-67.
26. Kikkawa Y., Sudo R., Kon J., et al. Laminin alpha 5 mediates ectopic adhesion of hepatocellular carcinoma through integrins and/or Lutheran/basal cell adhesion molecule. Exp. Cell Res. 2008, 314:2579-2590.
27. Le Naour F., Andre M., Greco C., et al. Profiling of the tetraspanin web of human colon cancer cells. Mol. Cell. Proteomics 2006, 5:845-857.